Search Results

Keywords: "United Kingdom"

First medical cannabis clinic in United Kingdom opens

Britain’s first dedicated medical marijuana clinic opened in Manchester, setting the groundwork for wider use of MMJ in the country and sparking criticism from some quarters of the medical community. More clinics are expected to open in London and Birmingham later this spring, according to a news release. Only a handful of patients have had access […]

Read More

United Kingdom sets date for first medical cannabis prescriptions

Specially trained doctors will be able to legally issue prescriptions for cannabis-based medicines for the first time in the United Kingdom starting Nov. 1, marking an important milestone for the medical marijuana industry in the country. The law introduced in the U.K. Parliament on Thursday will ultimately pave the way for one of the largest […]

Read More

United Kingdom legalizes medical cannabis prescriptions

Medical marijuana will be available by prescription in the United Kingdom by autumn after it was formally approved by the government Thursday.

After the UK’s medical cannabis market opens in the fall, it will immediately become one of the largest in Europe.

Read More

Aurora sends first shipment of ‘free’ marijuana to France

A subsidiary of Edmonton, Alberta-based Aurora Cannabis delivered its initial shipment of medical marijuana to France for use in the country’s pilot program, the company announced Wednesday. The program is reportedly set to start serving medical cannabis to patients at no charge in the coming weeks. Aurora was among companies from Australia, Canada, Israel and […]

Read More

Cannabis extractors are exploring THC remediation options

One is quick but expensive. The other is economical but slow – and tricky to get just right. Extractors looking to isolate certain cannabinoids have long relied on chromatography to dial up or down the many cannabinoids in marijuana and hemp plants. But a technique formerly derided as the mark of an inferior product – […]

Read More

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis producers benefiting, only businesses that have marketable intellectual property and an established foothold in the medical cannabinoid arena will draw serious […]

Read More

France chooses companies to supply free medical cannabis for trial program

The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot program that’s intended to provide free products to patients enrolled in the trial. Cannabis companies from Australia, Canada, Israel and the United Kingdom – in partnership with French pharmaceutical distributors – will provide […]

Read More

GW Pharma expects fiscal 2020 sales to reach $526 million

United Kingdom-based GW Pharmaceuticals expects to report annual sales of roughly $526 million for the year ended Dec. 31, 2020, the company said in a preview of its fourth-quarter and full-year results. Fourth-quarter net sales will be approximately $148 million, based on preliminary unaudited financial information, GW said. Epidiolex, the company’s most successful product, accounts […]

Read More

Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement

Canadian cannabis producer Canopy Growth Corp. is suing Britain’s GW Pharmaceuticals in U.S. federal court, alleging that GW is knowingly infringing upon Canopy’s intellectual property. GW uses a Canopy-patented method to extract the CBD that’s the active ingredient in its Epidiolex medication, according to a complaint filed Tuesday in the U.S. District Court for the Western […]

Read More